ADAPTHEALTH CORP
AHCONASDAQTrading Snapshot
- Day Range
- $5.58 – $5.73
- 52-Week Range
- $8.51 – $13.43
- Volume
- $2.15B
- Avg Volume
- $1.64B
- Shares Outstanding
- 136.1M
- Next Earnings
- Sep 29, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.27B
- Last Q Revenue
- $747M
- P/E Ratio
- —
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-0.59
- Dividend Yield
- —
Why Investors Own AHCO
- ✓High-growth profile — revenue up +48.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 64% gross margin and 26% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ADAPTHEALTH CORP
A company profile for ADAPTHEALTH CORP isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa., August 07, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences:
Which stocks have an unusual volume on Friday?
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $15 to $8.
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $9.
AdaptHealth: Fixed-Price Contracts Create Too Much Risk
AdaptHealth shares plunged after a deeply disappointing Q2, with a $1.07 loss and a $106 million revenue miss. Learn more about AHCO stock here.